Tassel C, Le Daré B, Morel I, Gicquel T. [Xenon: From rare gaz to doping product].
Presse Med 2016;
45:422-30. [PMID:
26922993 DOI:
10.1016/j.lpm.2016.01.025]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/06/2016] [Accepted: 01/20/2016] [Indexed: 11/17/2022] Open
Abstract
Doping is defined as the use of processes or substances to artificially increase physical or mental performance. Xenon is a noble gas used as an anesthetic and recently as a doping agent. Xenon is neuroprotective as an antagonist of NMDA glutamate receptors. Xenon stimulates the synthesis of erythropoietin (EPO) by increase of hypoxia inducible factor (HIF). Xenon would be a new doping product, maintaining doping methods ahead of detection.
Collapse